Alnylam Pharmaceuticals, Inc. (ALNY) Ownership — Institutional & Insider Holdings | MarketCI

AL

ALNY

Market Closed

Alnylam Pharmaceuticals, Inc.

US

2.23K employees

CEO: Yvonne L. Greenstreet

Founded: 2004

$278.09

+$0.00(+NaN%)

Market Cap

37.13B

Beta

0.27

52W Range

N/A

Dividend Yield

0.00%

Big Fish Trades and Ownership

In-depth analysis of ownership patterns and trading activity

Loading Senate trading data...

Explore ALNY

Key metrics and AI-powered insights

Price targets and earnings estimates

Income, balance sheet and cash flow

P/E, DCF and valuation multiples

Institutional and insider holdings

Analyst ratings and news sentiment

ALNY in the Healthcare

Large Cap

Browse sector stocks →

Browse industry stocks →